U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738926) titled 'PRL2019 in the Treatment of Juvenile Fibromyalgia' on July 15.
Brief Summary: Juvenile Fibromyalgia Syndrome (JFS) is a chronic condition affecting children and adolescents, characterised by widespread musculoskeletal pain and a significant impact on daily life and quality of life. Gastrointestinal symptoms and changes in gut microbiota have been reported in patients with fibromyalgia, suggesting a possible role of the gut-immune system interaction in the disease.
This study aims to investigate whether Gabapral(R), a food supplement containing the probiotic strain Bifidobacterium adolescentis PRL2019, may help reduce pain symptoms a...